RBC Capital analyst Natalia Webster raised the firm’s price target on Diaceutics (DIUXF) to 195 GBp from 165 GBp and keeps an Outperform rating on the shares.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DIUXF:
- Diaceutics Director Increases Stake Signaling Confidence in Company Growth
- Diaceutics Enhances Employee Incentive Program with Share Awards
- Diaceutics Reports Strong FY 2024 Growth and Positive Outlook
- Diaceutics Opens New US Headquarters to Boost Market Presence
- Diaceutics Unveils Pathology Engagement Service with $1.8m Contract